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Introduction
Leukotrienes (LTs) are intercellular messengers that are secreted by leukocytes and modulate the actions of neighboring cells (reviewed in (1) ). For example, LTB 4 potently attracts and activates leukocytes and in this way plays an important role in the normal inflammatory response. Indeed, the underproduction of leukotrienes results in impaired host defense, manifested as susceptibility to infection (2) . However, the overproduction of LTB 4 and cysteinyl LTs contributes to several diseases, most notably chronic inflammatory diseases, including asthma (3), fibrosis (4) and atherosclerosis (5) . Thus, processes that affect the capacity of leukocytes to synthesize and secrete leukotrienes are of clinical importance.
The enzyme 5-lipoxygenase (5-LO), in concert with the 5-LO activating protein (FLAP), initiates LT synthesis from arachidonic acid (AA), catalyzing its hydroperoxidation and dehydration to produce LTA 4 . This intermediate can then be converted by LTA 4 hydrolase to give LTB 4 or by LTC 4 synthase to produce LTC 4 . Also important in LT generation is the source of the substrate, AA. This fatty acid may be derived endogenously, released from membrane phospholipids by phospholipases (PL), including the group IV cytosolic PLA 2 (cPLA 2 ) (7).
Alternatively, AA may be exogenously derived, released from membrane phospholipids of neighboring cells by various PLA 2 s.
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Protein Purification and In Vitro PKA Phosphorylation Assay -GST fusion proteins were expressed in E. coli strain BL21 and purified on glutathione-Sepharose beads (Pharmacia) following manufacturer's instructions. Purified proteins were separated on a 10% SDS- were co-transfected with 2 µg of p5-LO or p5-LOS523A and increasing amounts of pCMVCα using Polyfect transfection reagent (Qiagen) following manufacturer's directions. To compare the intrinsic enzymatic activity of 5-LO and its mutant proteins S523A and S523E in vitro, 4 µg of plasmids expressing 5-LO, 5-LOS523A and S523E were transfected into cells and, 16 h post-transfection, the cell free activity in each lysate was determined as described above. Statistical Analysis -Statistical significance was evaluated by one-way ANOVA, using p<0.05
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as indicative of statistical significance. Pairs of group means were analyzed using the TukeyKramer post test. To evaluate if 5-LO is a direct target for PKA phosphorylation in vitro, we performed an in vitro PKA kinase assay using purified GST/5-LO fusion protein as target. Autoradiography of reaction products showed that the 104 kD fusion protein was phosphorylated by PKA and phosphorylation was inhibited by a PKA inhibitor peptide (PKI, Fig.2A ). Since GST is not phosphorylated by PKA (e.g., (36) ), this suggested that 5-LO was the target of PKA.
Results

Phosphorylation of 5-LO on
Phosphorylation of 5-LO by PKA was comparable to that of CREB, a known PKA substrate;
Coomassie staining of gels demonstrated comparable loading of purified proteins (Fig. 2B) .
Substitution of Ser523 with Ala on GST/5-LO strongly reduced phosphorylation as compared to WT GST/5-LO (Fig. 2B) . Slight residual phosphorylation suggested that an additional residue could be targeted by PKA under these optimal conditions. Mutation of the MAP kinaseactivated protein kinase site Ser271 did not reduce phosphorylation by PKA (Fig. 2B ). These 13 results indicated that 5-LO is phosphorylated, like CREB, by PKA in vitro, and Ser523 is the major site for phosphorylation by PKA. decreased, compared to cells without Calpha (Fig. 5A) ; the protein expression of 5-LO and FLAP in the cells was also comparable, as verified by immunoblotting (Fig. 5B) . These findings suggested that the inhibitory effect of Calpha on 5-LO metabolism directly resulted from its inhibition of 5-LO, and that Ser523 is pivotal for this inhibition.
Inhibition of LTB 4 Synthesis by
Role of Ser523 in the Effects of Native PKA -Proliferating 3T3 cells express native Calpha (Fig.   3 ) and may be expected to manifest a low level of PKA activation. Consistent with this, when 3T3 cells over-expressing GFP/5-LO were pretreated with 10 µM H-89, a selective PKA inhibitor, for 2 h and then stimulated with 10 µM A23187 plus 10 µM AA, LTB 4 synthesis was significantly greater compared to cells pretreated with vehicle (Fig. 6A) . In contrast, when cells were transfected with GFP/5-LO containing the S523A mutation, H-89 pretreatment had no significant effect on LTB 4 synthesis upon subsequent stimulation with A23187 plus AA ( Fig   6A) .
The effect of different PKA activators on LTB 4 synthesis was also tested. When 3T3 cells over-expressing GFP/5-LO were first treated with the adenylyl cyclase activator forskolin (50 µM) plus the phosphodiesterase inhibitor IBMX (45 µM) for 20 min and then stimulated with 10 µM A23187 plus 10 µM AA, LTB 4 synthesis was significantly decreased relative to vehicle pretreated cells (Fig. 6B) . Similarly, inhibition of LTB 4 synthesis was also found when transfected cells were pretreated with the stable cAMP analogue, dibutyryl cAMP (1 mM) for 20 min and then stimulated (Fig. 6B) . In contrast, cells over-expressing GFP/5-LO with the S523A mutation did not show decreased LTB 4 generation with either pretreatment (Fig. 6B) MAP kinase activation and impair membrane association of 5-LO (14) . The effects of PKA activity on membrane association of GFP/5-LO in 3T3 cells were tested by both cell-free and intact cell approaches. When 3T3 cells, co-transfected with pGFP/5-LO and pCMVneo, the parent vector of pCMV-Cα, were fractionated into soluble (S) and pelletable (P) microsomal membrane fractions in the absence of calcium, GFP/5-LO was detected in both fractions (Fig. 7A, left). When calcium was present during fractionation, significantly less GFP/5-LO was in the soluble fraction and more was in the membrane fraction, demonstrating calcium-dependent membrane association. Cells over-expressing both GFP/5-LO and Calpha, which led to impaired LTB 4 synthesis (Fig. 3) , showed normal membrane association of 5-LO: GFP/5-LO was present in both fractions in the absence of calcium and membrane-associated in the presence of calcium (Fig. 7A) . Since the presence of Calpha could not impair calcium-mediated in vitro membrane association of GFP/5-LO, mutation of Ser523 should not be expected to affect this process; indeed, the S523A mutant of GFP/5-LO showed normal membrane-association upon exposure to calcium, with or without over-expressed Calpha (Fig. 7A) .
Parallel experiments were performed to evaluate translocation of 5-LO in intact cells (Fig. 7A, right) . In these experiments, cells over-expressing GFP/5-LO (WT or the S523A mutant) with or without Calpha, were fractionated (without calcium) into soluble or microsomal membrane fractions, either before or after stimulation with calcium ionophore. The ability of PKA activation to block translocation of GFP/5-LO to membranes was also assessed visually by live cell microscopy. In resting 3T3 cells over-expressing GFP/5-LO, 5-LO is strongly accumulated in the nucleus but also evident in the cytoplasm (Fig. 7B) , as described previously (28 (Fig. 6) , also did not promote nuclear export of 5-LO (Fig. 8) . Similarly, treatment with H-89 (10 µM), which enhanced LTB 4 synthesis (Fig. 6 ),
did not promote nuclear import of 5-LO (Fig. 8) . This indicates that phosphorylation of 5-LO by PKA does not cause redistribution of 5-LO in the time frame used in these experiments. (Fig. 9C) . Immunoblotting of lysates showed that 5-LO protein expression was similar across all samples while Calpha protein was elevated when co-transfected (Fig. 9C) . Thus, PKA directly reduced 5-LO enzymatic activity, this was associated with a 10.9-fold decrease in the V/Km of 5-LO and inhibition of 5-LO by Calpha was eliminated when Ser523 was altered to Ala.
The prediction that insertion of a large negatively-charged side chain at site 523 inhibited catalytic activity was tested by replacing Ser523 with Glu (E). The lysates from cells overexpressing either WT 5-LO or the S523A 5-LO mutant showed comparable conversion of AA to the products 5-HPETE and 5-HETE, which co-elute as a single peak (Fig. 10A) . In contrast,
lysates from cells overexpressing S523E 5-LO produced no detectable product. Statistically, there was no significant difference between WT and S523A 5-LO, whereas the S523E mutant had less AA conversion to product (Fig. 10B ). All three constructs had comparable protein expression levels (Fig. 10B, inset) . These results support the model that phosphorylation at
Discussion
LTs are potent lipid mediators that evoke a large number of responses in target cells and tissues, including inflammation. It seems reasonable that mechanisms must exist for preventing the initiation of this signaling pathway, as well as for blunting or extinguishing the pathway after it has been initiated. We report here, for the first time, that activation of the cAMP signaling pathway directly inhibits LT synthesis through the phosphorylation of 5-LO by PKA. We provide evidence that PKA phosphorylates 5-LO on Ser523 and that mutation of Ser523 ameliorates the changes in LTB 4 synthesis caused by cAMP elevation and PKA activation. The motif that is recognized by Calpha is conserved across species, so that human 5-LO can be targeted by mouse Calpha, as shown in this study. Phosphorylation of 5-LO by PKA directly inhibits the catalytic activity of 5-LO, presumably through allosteric changes resulting from interactions between phosphorylated Ser523 and residues near Thr444. The direct inhibition of 5-LO following PKA activation, then, serves as a way for endogenous mediators, such as adenosine and PGE 2 , and therapeutic agents, such as β-adrenergic agonists, to rapidly reduce the capacity of leukocytes to generate LTs. This represents an additional mechanism by which PKA can regulate LT synthesis, beyond known actions to inhibit cPLA 2 activity and 5-LO translocation.
Examination of the crystal structure of rabbit reticulocyte 15-LO (1LOX.pdb; (38)) places the residue (Gln514), that corresponds to Ser523 on human 5-LO, at the periphery of the molecule (Fig. 11A ). This site was clearly distinct from the residues that correspond to those identified as lining the catalytic pocket of 15-LO (39, 40) . According to this model, Ser523
projects toward residues 441-444 (Lys-Asp-Leu-Thr), with closest association to the positive Lys441 and negative Asp442 (Fig. 11B) . Phosphorylation of Ser523 then would insert a large, 20 negatively charged polar phosphate group toward the 441-444 segment and potentially change conformation through residues linked to either 523 or 441-444, or both. Ser523 is close to an α-helix that includes both His550, which is essential for iron binding, and Gln557, which corresponds to the pocket-defining Gln547 on 15-LO (39). The 441-444 group is connected to three residues, Phe421, Ala424, and Asn425 which are critical for metabolism of AA by 15-LO (40, 41) . Thus, phosphorylation of Ser523 may cause allosteric changes that produce a 10-fold reduction in the V/Km of 5-LO (Fig. 9 ).
As noted above, a wide variety of treatments that elevate cAMP will inhibit LT synthesis.
This effect is wide-spread, being observed in all leukocytes. PKA activation inhibits cPLA 2 (22,23), a major source of AA for LT generation (7) . PKA activation can also block activation of p38 MAP kinase in neutrophils (14, 42) , and this can reduce LT synthesis by impeding the translocation of 5-LO to nuclear membranes (14) . Our results show that activated PKA inhibits In humans, the relentlessly progressive disease, idiopathic pulmonary fibrosis, is characterized by chronic LT overproduction (4, 46) . By contrast, macrophages (47) and fibroblasts (48) Data are means ± S.E of n = 3 independent transfections; *, p< 0.05 versus control. 
